RxDoctor Payments Data

Toni Lalla Torres, PA

Physician Assistant · Cutler Bay, FLNPI 1598024051

Payments from drug & device makers

$481in general payments, 2019–2025

Across 24 payments — averaging $20.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$157
  • AstraZeneca$91
  • Johnson & Johnson$80
  • Viiv Healthcare Company$69
  • Abbott$55
  • Merck$17
  • plus $12 from 1 others

What the payments were for

  • Food & beverage$481100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Gilead7$157
AstraZeneca4$91
Johnson & Johnson5$80
Viiv Healthcare Company3$69
Abbott3$55
Merck1$17
GSK1$12

How this compares

$481 in reported general payments places this provider in the 50th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$665
Medicare patients
31
Services billed
76

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala124$495,485
SymtuzaDarunavir/Cob/Emtri/Tenof Alaf74$378,735
PrezcobixDarunavir/Cobicistat48$123,673
JulucaDolutegravir/Rilpivirine36$118,467
TivicayDolutegravir Sodium42$97,596
OdefseyEmtricitab/Rilpiviri/Tenof Ala20$78,224
DovatoDolutegravir Sodium/Lamivudine21$68,050
GenvoyaElviteg/Cob/Emtri/Tenof Alafen17$65,508
OzempicSemaglutide39$44,517
IsentressRaltegravir Potassium21$40,772
Isentress HdRaltegravir Potassium12$27,319
FarxigaDapagliflozin Propanediol28$26,534
EliquisApixaban21$20,500
JanuviaSitagliptin Phosphate17$14,998
JardianceEmpagliflozin13$13,540

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadBiktarvy, Genvoya$157$560,993141 claims
Viiv Healthcare CompanyJuluca, Tivicay, Dovato$69$284,11299 claims
Johnson & JohnsonPrezcobix$80$123,67348 claims
MerckIsentress, Isentress Hd, Januvia$17$83,08950 claims
AstraZenecaFarxiga, Symbicort$91$28,97539 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Cutler Bay

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →